martes, 1 de abril de 2025

FDA Okays Perioperative Durvalumab Regimen for Muscle-Invasive Bladder Cancer Sharon Worcester, MA April 01, 2025

https://www.medscape.com/viewarticle/fda-okays-perioperative-durvalumab-regimen-muscle-invasive-2025a10007rs

No hay comentarios:

Publicar un comentario